Finance entity
Every one of those 1 sits in a single category, earnings. ASN-001 is most often covered alongside DESMODA, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 5.5 in the same window.
Last mentioned: 3d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, earnings. ASN-001 is most often covered alongside DESMODA, which appears in 1 of these 1 story. The 5 average consequence score is below the beat benchmark of 5.5 in the same window. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window. ASN-001 appears in 1 tracked Finance story from August 13, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering ASN-001. Shared-story counts are live from our verified record — not editorial picks.
Jefferson Capital dividend payable
Quarterly cash dividend of $0.24 per share is payable to shareholders.
Jefferson Capital dividend record date
Shareholders of record at close of business on August 24, 2026 qualify for the $0.24 per share dividend.
Q2 2026 earnings releases
Eton, Dawson, and Jefferson Capital report Q2 2026 financial results, with releases distributed at 20:30 UTC.
Q2 2026 reporting period ends
Eton Pharmaceuticals, Dawson Geophysical, and Jefferson Capital close the second quarter ended June 30, 2026.
HEMANGEOL relaunch
Eton relaunches HEMANGEOL in May 2026 with full Eton Cares patient support, including $0 copay for eligible patients.
Three Q2 2026 earnings releases from Eton Pharmaceuticals, Dawson Geophysical, and Jefferson Capital show strong revenue growth but uneven profitability. Finance readers should focus on revenue catalysts, margin expansion, and dividend sustainability.
ASN-001 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
